Hims & Hers Securities Fraud Class Action
Analysis based on 215 articles · First reported Jul 29, 2026 · Last updated Sep 22, 2026
The securities class action and the underlying FTC lawsuit have already caused a sharp decline in Hims & Hers stock, and the ongoing litigation could lead to further volatility and potential financial penalties. The case highlights regulatory risks in the telehealth sector, potentially affecting investor sentiment toward similar companies and prompting increased scrutiny of data privacy and billing practices.
Hims & Hers Health, Inc. and certain executives face a securities fraud class action lawsuit filed in the Northern District of United States — California (Velanki v. Hims & Hers Health, Inc., No. 26-cv-09313). The lawsuit alleges that during the class period from August 4, 2025 to July 29, 2026, the company made materially false and misleading statements and failed to disclose that it shared consumers' health information with third-party advertising platforms, charged consumers for prescriptions almost immediately after they submitted intake forms despite promising consultation with medical providers, and that these practices subjected the company to regulatory scrutiny and likely penalties. The lawsuit was triggered by the United States — Federal Trade Commission's July 29, 2026 lawsuit against Hims & Hers, joined by the State of United States — Utah and United States — Los Angeles County, California (representing United States — California), which accused the company of deceptive privacy and billing practices. On that news, Hims & Hers shares fell $4.32, or 14.73%, to close at $25.00, erasing over $970 million in market capitalization. The lead plaintiff deadline is November 2, 2026. Additionally, Visa Inc. reportedly placed Hims & Hers in its Acquirer Monitoring Program due to excessive customer complaints, resulting in surcharges. The company has disputed the FTC's claims, and CEO Andrew Dudum has defended its business model. The FTC has also pursued similar cases against other telehealth companies like BetterHelp and GoodRx.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard